在转移性激素敏感前列腺癌的三重疗法
Igor Tsaur1, Cristian Mirvald2,3, Cristian Surcel2,3
1Department of Urology and Pediatric Urology, University Medicine Mainz, Germany.
Current opinion in urology
|September 1, 2023
概括
结合雄激素剥夺疗法 (ADT) 与多塞塔塞尔 (D) 和一种新的激素剂 (NHA) 的新疗法显示,转移性激素敏感前列腺癌 (mHSPC) 的存活率有好处. 三重疗法对高体积的新发性疾病最有效.
科学领域:
- 在瘤学瘤学.
- 前列腺癌研究 研究前列腺癌
- 临床试验分析
背景情况:
- 转移性激素敏感前列腺癌 (mHSPC) 管理已经与组合疗法一起发展.
- 与新激素药物 (NHA) 或多塞 (D) 结合的雄激素剥夺疗法 (ADT) 提供了生存优势.
- 最近的试验研究了mHSPC的三重疗法 (ADT+D+NHA).
结论:
- 三重疗法 (ADT+D+NHA) 显示出显著的生存益处,特别是在新的高容量mHSPC.
- 对于超慢性或低体积的mHSPC,三重治疗的生存优势仍然不确定.
- 对于具有良好的瘤生物学患者来说,ADT+NHA可能足够,考虑到质量调整生存率.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


